Diabetes: Balancing your insulin, medication and exercise
The Madison Clinic serves a higher-than-average percentage of minority patients with type 1 diabetes, making it a good site for researching these differences. Roughly 25 percent of the clinics families are Latino, and African-American families are proportionately higher than in the overall U.S. population of patients with diabetes. Naranjo has gathered detailed information from 20 clinic families so far, using a combination of surveys and in-depth interviews with patients and family members. One emerging pattern, according to Naranjo, is that Latino parents do not necessarily value transition in the same way that the medical world does. The transition model used in medical settings is designed to help young adults take over monitoring their health, making their own appointments and interfacing with insurance companies or other agencies. Latino parents often wonder Why should I burden my child in that way? said Naranjo. Many Latino families continue living together longer into adulthood than non-Latino families, and consequently, parents continue to play a big role in their young adults diabetes management. Latino children may also look at the transition process differently, particularly if their parents are uninsured and struggling to treat their own chronic health problems, such as high blood pressure or type 2 diabetes.
For the original version including any supplementary images or video, visit http://www.ucsf.edu/news/2013/09/108881/madison-clinic-helps-young-diabetes-patients-manage-their-own-care
Diabetes Technology Society Outlines Potential Post-clearance Surveillance Program To Address Inaccuracy Of Blood Glucose Monitors
She is a certified diabetes educator (C.D.E.) and is currently in graduate school working on a Master of Science in nursing (M.S.N.) and health care education. Nancy works with adults who have type 1, type 2 and other forms of diabetes. Nancy is coordinator of the Diabetes Unit’s intensive insulin therapy program within the Division of Endocrinology, Diabetes, Metabolism, & Nutrition at Mayo Clinic in Rochester, Minn. Nancy has worked extensively with insulin pump therapy and continuous interstitial glucose sensing. Peggy Moreland, R.N., M.S.N. Peggy Moreland is a certified diabetes educator (C.D.E.) in the Division of Endocrinology, Diabetes, Metabolism, & Nutrition at Mayo Clinic in Rochester, Minn.
For the original version including any supplementary images or video, visit http://www.mayoclinic.com/health/insulin-and-exercise/MY02511/rss=1
9, the U.S. Food and Drug Administration (FDA), clinical experts and device manufacturers, at a meeting convened by the Diabetes Technology Society (DTS), discussed the need for improving post-market surveillance and quality assurance. During the meeting, DTS presented a plan to develop a mandatory post-market surveillance program that could provide independent assessment of FDA-cleared SMBG systems to ensure they maintain accuracy standards. The program would be led by a diverse steering committee and implemented in several labs across the U.S. and outside of the U.S. This program could deliver performance verification information to the FDA and generate information to assist patients, healthcare providers and payers with product selections.
For the original version including any supplementary images or video, visit http://www.sacbee.com/2013/09/13/5733229/diabetes-technology-society-outlines.html